ID
42252
Beschrijving
Study ID: 104864/410 Clinical Study ID: 104864/410 Study Title: A randomised open-label multicentre Phase II study to evaluate the safety and efficacy of intravenous topotecan given with either cisplatin or etoposide every 21 days as first-line therapy in patients with extensive-disease (ED) small-cell lung cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Study Indication: Lung Cancer
Trefwoorden
Versies (1)
- 20-04-21 20-04-21 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
20 april 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Safety and efficacy of topotecan in patients with extensive-disease small-cell lung cancer (104864/410)
Eligibility Criteria
- StudyEvent: ODM
Beschrijving
Inclusion Criteria
Alias
- UMLS CUI-1
- C1512693
Beschrijving
1. Written informed consent.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021430
Beschrijving
2. Age at least 18 years old.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0001779
Beschrijving
3. Patient has a histologically proven ED SCLC (See protocol Appendix F).
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0149925
- UMLS CUI [1,2]
- C0231449
Beschrijving
4. Patient has had no prior chemotherapy or immunotherapy.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0021083
Beschrijving
Measurable disease on CT or MRI scan must have one diameter >= 1 cm and one diameter >= 2 cm Measurable disease on chest X-ray must have both diameters >=2 cm. Palpable tumor masses that cannot be evaluated radiologically must have two diameters >= 2 cm. A measurable skin lesion must have at least one diameter >= 1 cm and it's presence must be evaluated by a photograph.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0221198
- UMLS CUI [1,2]
- C1513040
- UMLS CUI [1,3]
- C1705052
- UMLS CUI [2,1]
- C0221198
- UMLS CUI [2,2]
- C1522602
- UMLS CUI [3]
- C0040405
- UMLS CUI [4]
- C0024485
- UMLS CUI [5]
- C0031809
Beschrijving
6. It has been at least 3 weeks since any previous surgery (a lesser period is acceptable if deemed in the best interest of the patient).
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0205156
Beschrijving
Patients who have received palliative radiotherapy must have recovered from any reversible toxic effects. Permanent and stable side effects or changes are acceptable.
Datatype
boolean
Alias
- UMLS CUI [1]
- C3898008
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C0280962
Beschrijving
- haemoglobin >= 9.0 g/dL (after transfusion if needed) - WBC >= 3.5 x 10^9/L - neutrophils >= 1.5 x 10^9/L - platelets >= 100 x 10^9/L - creatinine <=1.5 mg/dL (133 micromol/L) - creatinine clearance >= 60 mL/min calculated using the Cockcroft Gault formula - serum bilirubin <= 2.0 mg/dL (34 micromol/L) - SGOT/AST, SGPT/ALT, and Alkaline Phosphatase <= 2 times the upper limit of normal if liver metastases cannot be visualised by abdominal CT or MRI scan; or <= 5 times the upper limit of normal if liver metastases are present.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0005953
- UMLS CUI [1,2]
- C0031843
- UMLS CUI [2]
- C0232804
- UMLS CUI [3]
- C0232741
Beschrijving
9. Patient has an ECOG performance status of 0, 1, or 2 (see protocol Appendix C).
Datatype
boolean
Alias
- UMLS CUI [1]
- C1520224
Beschrijving
10. Patient has a predicted life expectancy of at least 3 months at screening.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0023671
- UMLS CUI [2]
- C0220908
Beschrijving
11. Patient is not of reproductive potential, or if the patient is of reproductive potential the patient agrees to practice an effective method of contraception.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0015895
- UMLS CUI [2]
- C0700589
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
1. Patient is female and is pregnant or lactating.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
2. Patient is of child bearing potential and is refusing to practice an effective method of contraception.
Datatype
boolean
Alias
- UMLS CUI [1]
- C3831118
- UMLS CUI [2]
- C0700589
Beschrijving
3. Patient has an uncontrolled infection.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009450
- UMLS CUI [1,2]
- C0205318
Beschrijving
4. Patient has previous or concomitant malignancies at other sites within the last 5 years excepting basal or squamous cell carcinoma of the skin and carcinoma in situ of the cervix or stage A low grade prostate cancer.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
- UMLS CUI [2,1]
- C1515974
- UMLS CUI [2,2]
- C0205394
- UMLS CUI [3]
- C0007117
- UMLS CUI [4]
- C0007137
- UMLS CUI [5]
- C0851140
- UMLS CUI [6]
- C0280280
Beschrijving
5. Patient has only undimensionally measurable or evaluable disease.
Datatype
boolean
Alias
- UMLS CUI [1]
- C1513041
- UMLS CUI [2]
- C1516986
Beschrijving
A patient with brain and/ or leptomeningeal metastases on CT or MRI scan may be included only if he/ she is asymptomatic on neurological exam and is not receiving corticosteroid therapy to control symptoms)
Datatype
boolean
Alias
- UMLS CUI [1]
- C0037088
- UMLS CUI [2]
- C0220650
- UMLS CUI [3]
- C1704231
- UMLS CUI [4]
- C0040405
- UMLS CUI [5]
- C0024485
Beschrijving
7. Patient has concurrent severe medical problems unrelated to the malignancy which would significantly limit full compliance with the study or expose the patient to extreme risk or decreased life expectancy.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0205082
- UMLS CUI [2,1]
- C0006826
- UMLS CUI [2,2]
- C0439849
- UMLS CUI [3]
- C1321605
- UMLS CUI [4,1]
- C0205403
- UMLS CUI [4,2]
- C0035647
- UMLS CUI [5,1]
- C0023671
- UMLS CUI [5,2]
- C0547047
Beschrijving
8. Patient has received an investigational drug within 30 days or five half-lives prior to entry into the study (whichever is longer).
Datatype
boolean
Alias
- UMLS CUI [1]
- C0304229
- UMLS CUI [2,1]
- C0008976
- UMLS CUI [2,2]
- C0332152
Beschrijving
Radiotherapy may be given concomitantly for the palliative control of bone pain, however not all measurable or evaluable lesions should be included in the irradiated field.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3665472
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [2,1]
- C0021083
- UMLS CUI [2,2]
- C0205394
- UMLS CUI [3]
- C0149925
Beschrijving
10. Patient has a pre-existing cardiac disease, including congestive heart failure, arrhythmia's requiring treatment, or myocardial infarction within the preceding 3 months.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0018799
- UMLS CUI [1,2]
- C2347662
- UMLS CUI [2]
- C0018802
- UMLS CUI [3,1]
- C0003811
- UMLS CUI [3,2]
- C0087111
- UMLS CUI [4]
- C0027051
Beschrijving
11. Patient has any other condition for which treatment with any of the drugs used in this study are contraindicated.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C0013227
- UMLS CUI [3]
- C1301624
Beschrijving
Inclusion/ Exclusion
Alias
- UMLS CUI-1
- C1512693
- UMLS CUI-2
- C0680251
Beschrijving
Investigator's Signature
Alias
- UMLS CUI-1
- C2346576
Similar models
Eligibility Criteria
- StudyEvent: ODM
C0231449 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2])
C1513040 (UMLS CUI [1,2])
C1705052 (UMLS CUI [1,3])
C0221198 (UMLS CUI [2,1])
C1522602 (UMLS CUI [2,2])
C0040405 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
C0031809 (UMLS CUI [5])
C0205156 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2])
C0280962 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0220908 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
C0205318 (UMLS CUI [1,2])
C1515974 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0007117 (UMLS CUI [3])
C0007137 (UMLS CUI [4])
C0851140 (UMLS CUI [5])
C0280280 (UMLS CUI [6])
C1516986 (UMLS CUI [2])
C0220650 (UMLS CUI [2])
C1704231 (UMLS CUI [3])
C0040405 (UMLS CUI [4])
C0024485 (UMLS CUI [5])
C0205082 (UMLS CUI [1,2])
C0006826 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C1321605 (UMLS CUI [3])
C0205403 (UMLS CUI [4,1])
C0035647 (UMLS CUI [4,2])
C0023671 (UMLS CUI [5,1])
C0547047 (UMLS CUI [5,2])
C0008976 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0205394 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0149925 (UMLS CUI [3])
C2347662 (UMLS CUI [1,2])
C0018802 (UMLS CUI [2])
C0003811 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C0205394 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3])
C0680251 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])